STOCKBIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)Updated 2026-08-16
Here’s whether Gilead Sciences Inc (GILD) is worth buying in 2026 —
based on weekly-updated price trend, RSI momentum, and return vs.
the S&P 500. Our current read: Bullish.
🟢
Bullish
Positives: trading above the 200-day MA (long-term uptrend intact); above the 50-day MA (medium-term momentum positive); 50-day MA is rising (+0.34% over 10 days); strong 1-year return of +16.2%; 3-month momentum positive (+6.8%). Currently 12.0% off its 52-week high. Score: +6/7.
GILD is in a confirmed uptrend, trading above both its 50-day ($130.18) and 200-day ($132.45) moving averages. An RSI of 65.6 sits in the neutral zone — momentum is neither stretched nor exhausted. The 1-year return of +16.3% compares to +20.4% for SPY (trailed the market by 4.1%).
$10,000 invested 1 year ago→ $11,625 today
vs. S&P 500 (SPY) — same period trailed market by 4.1%
1-Year Price Chart
Daily candles
MA-50MA-200UpDown
Signal Check
✓Above 200-day MA ($132.45)
✓Above 50-day MA ($130.18)
✓RSI(14) neutral zone (30–70) — currently 65.6
✓Positive return (+16.3%)
!Within 10% of period high (−12.0%)
Period Range $138.36
$108.46$157.29
RSI (14) 65.6
0 · OversoldOverbought · 100
Key Metrics
Price$138.36
Period Return+16.3%
Period High$157.29
Period Low$108.46
Drawdown−12.0%
MA-50$130.18
MA-200$132.45
RSI (14)65.6
Avg Volume (30d)6.8M
vs. SPYtrailed by 4.1%
Return Rank#514 of 1252
Trend Signals
Price is above the 200-day moving average ($132.45)
Price is above the 50-day moving average ($130.18)